De novo MAPK1 variants promoting hyperactivation of the kinase cause a neurodevelopmental disorder within the RASopathy phenotypic spectrum (Motta, Pannone, et al., 2020; Motta, Sagi‐Dain, et al., 2020). This evidence concerns the gene MAPK1 and RASopathy.